NCT04461015View on ClinicalTrials.gov

The Effect of the Interaction of Glucagon and Insulin on Endogenous Glucose Production in Humans

PHASE3CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 14, 2020

Primary Completion Date

July 30, 2021

Study Completion Date

January 6, 2022

Conditions
Healthy
Interventions
DRUG

0.4mU Insulin followed by withdrawal period followed by 0.8mU study

Clamp study with insulin infused at 0.4 mU/Kg/min, followed by a 2 week withdrawal period followed by a clamp study with insulin infused at 0.8 mU/Kg/min

DRUG

0.8mU Insulin followed by withdrawal period followed by 0.4mU study

Clamp study with insulin infused at 0.8 mU/Kg/min, followed by a 2 week withdrawal period followed by a clamp study with insulin infused at 0.4 mU/Kg/min

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

All Listed Sponsors
lead

Adrian Vella

OTHER

NCT04461015 - The Effect of the Interaction of Glucagon and Insulin on Endogenous Glucose Production in Humans | Biotech Hunter | Biotech Hunter